Regeneron Pharmaceuticals
REGN
#282
Rank
โ‚น7.265 T
Marketcap
โ‚น68,553
Share price
-1.18%
Change (1 day)
10.83%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น446.36 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.24 Billion. In 2024 the company made an earning of โ‚น431.77 Billion, an increase over its 2023 earnings that were of โ‚น379.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น446.36 B3.38%
2024 โ‚น431.77 B13.83%
2023 โ‚น379.32 B-13.57%
2022 โ‚น438.90 B-47.9%
2021 โ‚น842.40 B144.75%
2020 โ‚น344.19 B56.86%
2019 โ‚น219.42 B-4.87%
2018 โ‚น230.66 B22.86%
2017 โ‚น187.75 B56.3%
2016 โ‚น120.12 B8.55%
2015 โ‚น110.66 B54.53%
2014 โ‚น71.61 B11.14%
2013 โ‚น64.43 B72.13%
2012 โ‚น37.43 B-285.93%
2011 -โ‚น20.14 Billion121.73%
2010 -โ‚น9.09 Billion37.18%
2009 -โ‚น6.62 Billion-14.6%
2008 -โ‚น7.76 Billion-25.02%
2007 -โ‚น10.34 Billion6.32%
2006 -โ‚น9.73 Billion-186.52%
2005 โ‚น11.23 B2103.7%
2004 โ‚น0.51 B-105.66%
2003 -โ‚น9.02 Billion-18.18%
2002 -โ‚น11.02 Billion42.33%
2001 -โ‚น7.74 Billion129.35%
2000 -โ‚น3.38 Billion51.87%
1999 -โ‚น2.23 Billion92.19%
1998 -โ‚น1.16 Billion66.23%
1997 -โ‚น0.7 Billion-55.49%
1996 -โ‚น1.57 Billion103.53%
1995 -โ‚น0.77 Billion-70.89%
1994 -โ‚น2.64 Billion-26.08%
1993 -โ‚น3.57 Billion114.67%
1992 -โ‚น1.67 Billion196.77%
1991 -โ‚น0.57 Billion87.88%
1990 -โ‚น0.3 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น744.68 B 60.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.77 B-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น171.99 B-62.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.926 T 529.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.483 T 219.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚น822.03 B 76.87%๐Ÿ‡ซ๐Ÿ‡ท France